Real Estate - Services
Compare Stocks
2 / 10Stock Comparison
REAX vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REAX vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities |
| Market Cap | $436M | $150.14B |
| Revenue (TTM) | $1.97B | $11.63B |
| Net Income (TTM) | $-8M | $1.43B |
| Gross Margin | 8.4% | 39.1% |
| Operating Margin | -0.4% | 4.4% |
| Forward P/E | — | 78.9x |
| Total Debt | $0.00 | $21.38B |
| Cash & Equiv. | $60M | $5.03B |
REAX vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | May 26 | Return |
|---|---|---|---|
| The Real Brokerage … (REAX) | 100 | 549.9 | +449.9% |
| Welltower Inc. (WELL) | 100 | 414.1 | +314.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: REAX vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
REAX is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 55.7%, EPS growth 73.6%, 3Y rev CAGR 72.8%
- 338.1% 10Y total return vs WELL's 230.2%
- 55.7% FFO/revenue growth vs WELL's 35.8%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 55.7% FFO/revenue growth vs WELL's 35.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs REAX's -0.4% | |
| Stability / Safety | Beta 0.13 vs REAX's 1.60 | |
| Dividends | 1.3% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +43.9% vs REAX's -51.1% | |
| Efficiency (ROA) | 2.3% ROA vs REAX's -6.2%, ROIC 0.5% vs -15.9% |
REAX vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
REAX vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 5.9x REAX's $2.0B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to REAX's -0.4%. On growth, REAX holds the edge at +44.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.0B | $11.6B |
| EBITDAEarnings before interest/tax | -$7M | $2.8B |
| Net IncomeAfter-tax profit | -$8M | $1.4B |
| Free Cash FlowCash after capex | $74M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +8.4% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -0.4% | +4.4% |
| Net MarginNet income ÷ Revenue | -0.4% | +12.3% |
| FCF MarginFCF ÷ Revenue | +3.8% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +44.1% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +42.4% | +22.5% |
Valuation Metrics
REAX leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $436M | $150.1B |
| Enterprise ValueMkt cap + debt − cash | $376M | $166.5B |
| Trailing P/EPrice ÷ TTM EPS | -55.28x | 154.17x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.76x |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 14.08x |
| Price / BookPrice ÷ Book value/share | 8.70x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 6.72x | 52.72x |
Profitability & Efficiency
WELL leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-17 for REAX. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs REAX's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -17.4% | +3.5% |
| ROA (TTM)Return on assets | -6.2% | +2.3% |
| ROICReturn on invested capital | -15.9% | +0.5% |
| ROCEReturn on capital employed | -20.3% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x |
| Net DebtTotal debt minus cash | -$60M | $16.3B |
| Cash & Equiv.Liquid assets | $60M | $5.0B |
| Total DebtShort + long-term debt | $0 | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -15.34x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $10,851 for REAX. Over the past 12 months, WELL leads with a +43.9% total return vs REAX's -51.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs REAX's 18.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -44.7% | +15.0% |
| 1-Year ReturnPast 12 months | -51.1% | +43.9% |
| 3-Year ReturnCumulative with dividends | +67.2% | +182.2% |
| 5-Year ReturnCumulative with dividends | +8.5% | +212.6% |
| 10-Year ReturnCumulative with dividends | +338.1% | +230.2% |
| CAGR (3Y)Annualised 3-year return | +18.7% | +41.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than REAX's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.6% from its 52-week high vs REAX's 37.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.60x | 0.13x |
| 52-Week HighHighest price in past year | $5.41 | $219.59 |
| 52-Week LowLowest price in past year | $1.92 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +37.7% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 36.1 | 62.6 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 2.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates REAX as "Buy" and WELL as "Buy". Consensus price targets imply 108.3% upside for REAX (target: $4) vs 5.7% for WELL (target: $227). WELL is the only dividend payer here at 1.29% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $4.25 | $226.50 |
| # AnalystsCovering analysts | 7 | 34 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.0% | 0.0% |
WELL leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). REAX leads in 1 (Valuation Metrics).
REAX vs WELL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is REAX or WELL a better buy right now?
For growth investors, The Real Brokerage Inc.
(REAX) is the stronger pick with 55. 7% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Welltower Inc. (WELL) offers the better valuation at 154. 2x trailing P/E (78. 9x forward), making it the more compelling value choice. Analysts rate The Real Brokerage Inc. (REAX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — REAX or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to +8. 5% for The Real Brokerage Inc. (REAX). Over 10 years, the gap is even starker: REAX returned +338. 1% versus WELL's +230. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — REAX or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus The Real Brokerage Inc. 's 1. 60β — meaning REAX is approximately 1105% more volatile than WELL relative to the S&P 500.
04Which is growing faster — REAX or WELL?
By revenue growth (latest reported year), The Real Brokerage Inc.
(REAX) is pulling ahead at 55. 7% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: The Real Brokerage Inc. grew EPS 73. 6% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, REAX leads at 72. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — REAX or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -0. 4% for The Real Brokerage Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -0. 4% for REAX. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is REAX or WELL more undervalued right now?
Analyst consensus price targets imply the most upside for REAX: 108.
3% to $4. 25.
07Which pays a better dividend — REAX or WELL?
In this comparison, WELL (1.
3% yield) pays a dividend. REAX does not pay a meaningful dividend and should not be held primarily for income.
08Is REAX or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +230. 2% 10Y return). The Real Brokerage Inc. (REAX) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +230. 2%, REAX: +338. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between REAX and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
WELL pays a dividend while REAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.